|
GTBP Gt Biopharma Inc 109657 |
| Income Statement |
|
Net Income
|
form10-k
|
-13,162,000 |
| Balance Sheet |
|
Current Assets
|
4,232,000 |
|
Assets
|
4,232,000 |
|
Current Liabilities
|
5,902,000 |
|
Liabilities
|
5,902,000 |
|
Equity
|
-1,670,000 |
|
Shares Out
|
2,234,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-12,904,000 |
|
Investing Cash Flow
|
12,893,000 |
| Market Analysis |
Market Cap
|
4,759,346 |
|
Price
|
2.43 |
|
BVPS
|
0.75 |
|
PB
|
3.28 |
|
EPS
|
-7.72 |
|
PS
|
149.45 |
|
FCF
|
-11,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/21 |
-6.94 |
|
-0.77 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GTBP documents filed with the SEC.
GTBP Filings
Clear
